The National Times - Social media fuels surge in UK men seeking testosterone jabs

Social media fuels surge in UK men seeking testosterone jabs


Social media fuels surge in UK men seeking testosterone jabs
Social media fuels surge in UK men seeking testosterone jabs / Photo: © AFP

Social media claims by clinics promoting testosterone treatment for men to improve their physique and mood are driving large numbers to pay for unnecessary medication that can have serious side effects, doctors say.

Change text size:

Men's hormone levels can fluctuate for lifestyle reasons but many are being prescribed testosterone replacement therapy (TRT) without medical need despite the health risks, doctors in the UK and Australia told AFP.

Promotional campaigns by private clinics use social media and influencers, as well as an ad campaign in the London Underground, to encourage young body-conscious men to test their levels, claiming fatigue or irritation are symptoms.

"Do you wish you could have more energy? Less body fat? A higher sex drive?" asks one ad.

Costly treatments could be the answer.

The trend is now affecting the state-funded National Health Service, since many seek free treatment there.

The number of men referred to NHS specialists after being diagnosed privately "has really exploded", said Channa Jayasena, a professor of endocrinology at Imperial College.

"It's a huge problem for us, which is impacting our ability to treat other patients."

TRT is needed by those with true deficiency, known as hypogonadism, including men who never went through puberty or had testicular cancer.

But some clinics prescribe it to men with normal levels and risking side-effects including infertility and thickened blood that carries cardiovascular risks, doctors warn.

While private clinics are not obliged to disclose numbers, Jayasena estimated "hundreds of thousands" of men in the UK have accessed costly TRT privately.

And most "just don't need it at all", he said.

- Manosphere -

Isobelle Smith, an endocrinologist in New South Wales, Australia, has made Instagram videos debunking TRT claims.

"I've seen the advertising that up to one in four or one in five men before the age of 40 have testosterone deficiency -- that is just absolutely not true," she told AFP.

"These companies are saying that essentially normal levels are low," she said.

"Really, it's performance-enhancing drugs."

Some link the TRT craze to the "manosphere" culture with its fixation on bulging muscles and longevity.

Misogynist influencer Andrew Tate claims to have "high T" and berates men with "low T". US Health Secretary Robert F. Kennedy Jr. recently extolled President Donald Trump's high levels.

Data on private clinics is not available, but prescriptions for testosterone by family doctors rose 13 percent in 2024 in England, according to the Care Quality Commission regulator.

The NHS in England spent over £30 million ($40.1 million) in 2024 on testosterone jabs and gels, according to the OpenPrescribing website. Some were used for gender change and women's health.

Studies in the United States and Europe have shown testosterone levels declining for decades, which scientists link to lifestyle and environmental factors.

Despite the scepticism from medical professionals, men told AFP they had felt the positive effects of TRT.

Gavin McNamee, a 41-year-old personal trainer from northeast England, said he had had poor mental health and low energy. But after five months of treatment, he said: "I just feel so much better".

"I feel like a different person," agreed Carl Graham, a 38-year-old legal administrator from Liverpool on TRT for over six months.

Neither man consulted NHS doctors, and both inject testosterone prescribed privately, paying £100 to £200 a month.

- 'Take a test' -

Heavily-muscled influencers promote clinics offering TRT via gels, pills or injections.

Jayasena said images of "men with six-packs even in their 50s and 60s", such as Amazon founder Jeff Bezos, had great sway.

Advertising testosterone, like any prescription-only medicine, is illegal in the UK.

But private clinics circumvent this by advertising blood tests.

"Feeling tired, unfocused, or taking longer to recover after workouts? It could be time to check your testosterone levels," reads one ad for Harley Street TRT provider.

"If you don't feel like you're firing on all cylinders, take a test," ex-commando and television personality Jason Fox says in a video promoted by online provider Voy.

The ads appear to target young men, and Harley Street TRT has a "25 plus" setting on its Meta ads, offering personal trainers £50 per referral.

Each patient generates an "average £1,500 ($2,000) profit per year," it says.

G.Waters--TNT

Featured

Carney touts Canada 'pivot' away from US as Trump levels new threat

Canadian Prime Minister Mark Carney said Tuesday that reducing economic ties with the United States would come at a cost but the benefits were clear, as President Donald Trump threatened new penalties targeting Canada.

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Change text size: